Investigation and a pending class action lawsuit on behalf of direct purchasers of the anti-AIDS medicines Norvir and Kaletra.
Norvir serves as a "booster" to prolong the efficacy of other anti-AIDS drugs. Kaletra is a combination of the active ingredient in Norvir and another AIDS drug. The class action lawsuit alleges that Abbott Laboratories quadrupled the price for Norvir, while selling Kaletra below Abbott's cost. These actions were taken in order to simultaneously increase sales of Kaletra and to suppress sales of competitors' AIDS treatments which depend on Norvir as a stand-alone product.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Abbott is a medical devices and pharmaceutical company with almost $30 billion in sales for 2008. Abbott employees 72,000 people worldwide at over 100 locations
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.